BIGG

Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines

Wu, Lei; Chen, Yaolong; Ma, Yanfang; Yang, Zifeng; Yang, Nan; Denga, Wenze; Chen, Yuanbin; Sun, Yuanyuan; Li, Yimin; Lin, Lin.

Pharmacol. res; 160 (), 2020

Influenza is a major public health problem worldwide. Mutations and resistance development make the use of antiviral therapy challenging. Chinese patent medicines are often used to treat influenza in China and well tolerable. However, the misuse of Chinese patent medicines is common. We therefore aimed t...

Gripe Humana/prevención & control, Gripe Humana/tratamiento farmacológico, Práctica Farmacéutica Basada en la Evidencia, Medicina Tradicional China, Patente, Antivirales/uso terapéutico, Oseltamivir/uso terapéutico, Medicamento Fitoterápico

Texto completo

WHO Guidelines for pharmacological management of pandemic Influenza A(H1N1) 2009 and other influenza viruses: part I recommendations

The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...